Gyas Khan

Years Active: 2023-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Gyas Khan, Mohammad Firoz Alam, Saeed Alshahrani, Yosif Almoshari, Abdulmajeed M Jali, Saud Alqahtani, Mohammad Khalid, Shehla Nasar Mir Najib Ullah, Tarique Anwer
Trastuzumab-Mediated Cardiotoxicity and Its Preventive Intervention by Zingerone through Antioxidant and Inflammatory Pathway in Rats. Journal of personalized medicine 13 (5) (2023)
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Manal A Alossaimi, Waleed H Almalki, Abdulaziz Alzahrani, Muhammad Abul Barkat, Tahani M Almeleebia, Hanan M Alshareef, Eman Mohammed Shorog, Gyas Khan, Tanuja Singh, J K Singh
Bedaquiline-Loaded Solid Lipid Nanoparticles Drug Delivery in the Management of Non-Small-Cell Lung Cancer (NSCLC). Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Hissana Ather, Shaheen Sultana, Waleed H Almalki, Pragya Bharti, Ankit Sahoo, Khusbu Dwivedi, Gyas Khan, Shahnaz Sultana, Abdulaziz Alzahrani, Mahfoozur Rahman
Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art. Biomedicines 11 (6) (2023)
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Hissana Ather, Shaheen Sultana, Waleed H Almalki, Pragya Bharti, Ankit Sahoo, Khusbu Dwivedi, Gyas Khan, Shahnaz Sultana, Abdulaziz Alzahrani, Mahfoozur Rahman
Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art. Biomedicines 11 (6) (2023)

Gyas Khan.css-eqlu8i{font-size:small;padding-left:4px;}